Dr Antonella Santuccione Chadha joins the Board of Directors at Bottneuro
It is an honor to welcome Dr. Antonella Santuccione Chadha to the Board of Directors at Bottneuro AG - bringing her extensive expertise to build our clinical strategy, supporting the company’s mission to bring precision neuromodulation solutions to Alzheimer’s disease and beyond.
Bottneuro Announces Leadership Changes
Dr Thomas Hefti is joining as Chief Executive Officer of Bottneuro AG, Switzerland as of June 1. Dr Bekim Osmani, co-founder and current CEO, will assume the role as Group CEO and Chairman of the Board.
Bottneuro Launches Miamind.ch
Bottneuro AG announces the launch of miamind.ch, the official online platform for the Miamind® Neurostimulator.
